|Bid||0.00 x 1200|
|Ask||9.62 x 900|
|Day's Range||9.33 - 9.91|
|52 Week Range||3.75 - 16.86|
|Beta (3Y Monthly)||4.12|
|PE Ratio (TTM)||32.11|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cannabis stocks were mostly higher Friday, as investors digested earnings from Canopy Growth Corp. and the news that Aphria Inc.’s probe of acquisitions in Latin America found certain board members had conflicts.
Canadian cannabis company Aphria Inc. said Friday a special committee has concluded a review of the acquisition of Latam Holdings Inc. and found conflicts of interest for some of its board members.
Cannabis producer Aphria said an independent review of its dealmaking in Latin America and the Caribbean uncovered "conflicting interests" but that prices paid were "within an acceptable range."
HENDERSON, NV / ACCESSWIRE / February 15, 2019 / With Cannabis companies already having an amazing 2019, we decided to hunt for the next potential breakout candidate. We searched amongst lesser known companies ...
Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.
Canopy Growth Rises after Earnings BeatCanopy Growth risesCanopy Growth (WEED) (CGC) was trending higher by 5% when markets opened. The company reported its earnings late last evening at around 8:45 PM EST.The company reported strong top-line
Analyzing Canopy Growth's Q3 Results(Continued from Prior Part)Canopy Growth’s losses widenIn the third quarter, Canopy Growth (WEED) (CGC) reported an operating loss of 157.2 million Canadian dollars, which widened from an operating loss of 26
Gauging Canadian Marijuana LP's off of current earnings results is a fool's errand. So much capital has been put into attempts to ramp up production, while the benefits of that production have yet to materialize.
The stock has gained more than 60 percent so far this year amid a hostile takeover battle with Green Growth Brands Inc. John Cervini, a co-founder of Aphria and its vice president of infrastructure and technology, will step down as a director effective March 1, but will remain in a “non-executive operational capacity,” the company said Friday. Chief Executive Officer Vic Neufeld and co-founder Cole Cacciavillani, who announced their plan to transition out of executive roles last month, will also step down as directors and retire effective March 1.
HENDERSON, NV / ACCESSWIRE / February 15, 2019 / Pain relief medicines are a massive market 30 billion doses of which are consumed each year in the US alone. Opioids like codeine and hydrocodone are also ...
HENDERSON, NV / ACCESSWIRE / February 15, 2019 / Below are a few of the hottest plays on the market right now. There's still time to make money on them so do your due diligence immediately. The first company ...
Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aphria Inc (APHA), Canopy Growth Corp (CGC), and Cronos Group Inc (CRON) represent four pot stocks looking to close out a strong week. Premier Health Group (OTC:PHGRF) (CSE:PHGI) is unlike many companies in the cannabis sector because its core framework is built around healthcare. The Company is largely focused on meeting the growing challenges of the healthcare industry through investments in advanced telemedical technologies and other innovations.
Aphria Inc. said Friday a special committee has concluded a review of the acquisition of Latam Holdings Inc. and found that the price paid was comparable to rival deals. However, "based on further information available to the Special Committee, it appears that certain of the non-independent directors of the Company had conflicting interests in the Acquisition that were not fully disclosed to the Board," the company said in a statement. Aphria appointed the special committee in early December to review the deal, which was completed in September, after it came under fire from short seller Quintessential Capital Management, which said the C$280 million ($211 million) Latin America acquisitions raised "major red flags," as its research suggested they appeared largely worthless. On Friday, Aphria said the assets in Argentina, Colombia and Jamaica "were verified to be in place and continued to develop according to the Company's business plan since the Acquisition, consistent with Aphria's previous public disclosure." The deal was deemed to be within an acceptable range compared with similar acquisitions by competitors, albeit near the top of the range. The company will improve its corporate governance by ensuring the majority of its board are independent directors and will deliver training to management and board members; it will adopt best practices to manage potential conflicts of interest including disclosure of all direct or indirect ownership interests and rely more on experts and advisers. As previously announced, CEO Vic Neufeld and co-founder Cole Cacciavillani have completed a transition plan and effective March 1, 2019 will be retiring and surrendering their roles as directors, although they will remain in place as advisers. Irwin Simon, independent chair, will remain as interim CEO until a new one has been found. Shares rose more than 8% premarket and are up about 60% in 2019, while the S&P 500 has gained 0.5%.
LEAMINGTON, ON , Feb. 15, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Board of Directors (the "Board") has accepted and considered the report of the special committee of independent directors (the "Special Committee"), which reviewed the allegations made against the Company in respect of the Company's previously completed acquisition of LATAM Holdings Inc. (the "Acquisition").
CORAL GABLES, FL / ACCESSWIRE / February 14, 2019 / What's incredible about the marijuana stock market is the sheer amount of excitement surrounding companies in the cannabis industry. As we've seen over the course of the past few years, more countries have brought forth legislation in favor of legalizing marijuana for recreational, as well as medicinal, purposes, and as a result, companies in the space have seen an influx in investor attention. If companies continue like this, the marijuana industry may see impressive gains as a result of favorable public opinions.
After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback at the start of this year on the renewed appeal for riskier assets. Here's why ETFs are riding high this year.
Cannabis Stocks Fall before Canopy Growth's EarningsCannabis stocks Before Canopy Growth’s (WEED) (CGC) earnings, most cannabis stocks fell. Canopy Growth fell nearly 1.6% at 11:45 PM EST on February 14. The cannabis sector ETF, the Horizons
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how recent developments in the EU Parliament as well as WHO (World Health Organization) could have massive impacts on the cannabis market and which companies are preparing for this next step in the radically expanding sector. In breaking news yesterday, the European Parliament passed a resolution calling on the European Commission and EU countries to provide a legal definition and draw a clear distinction between cannabis-based medicines approved by regulatory bodies, MMJ not supported by clinical trials, and other applications of the plant.
With Aurora Cannabis and most other marijuana stocks, sentiment and short squeezes are directing price action.